Found: 63
Select item for more details and to access through your institution.
Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM‐HF, INOVATE‐HF, and NECTAR‐HF.
- Published in:
- ESC Heart Failure, 2020, v. 7, n. 1, p. 75, doi. 10.1002/ehf2.12592
- By:
- Publication type:
- Article
Clinical Implications of QRS Duration in Patients Hospitalized With Worsening Heart Failure and Reduced Left Ventricular Ejection Fraction.
- Published in:
- JAMA: Journal of the American Medical Association, 2008, v. 299, n. 22, p. 2656, doi. 10.1001/jama.299.22.2656
- By:
- Publication type:
- Article
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart Failure.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 12, p. 1332, doi. 10.1001/jama.297.12.1332
- By:
- Publication type:
- Article
Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 12, p. 1319, doi. 10.1001/jama.297.12.1319
- By:
- Publication type:
- Article
Natriuretic peptides and cardiovascular events: more than a stretch.
- Published in:
- 2007
- By:
- Publication type:
- commentary
Natriuretic Peptides and Cardiovascular Events.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial.
- Published in:
- Heart Failure Reviews, 2012, v. 17, n. 3, p. 485, doi. 10.1007/s10741-011-9280-0
- By:
- Publication type:
- Article
Mechanical circulatory support devices for acute heart failure syndromes: considerations for clinical trial design.
- Published in:
- Heart Failure Reviews, 2009, v. 14, n. 2, p. 101, doi. 10.1007/s10741-008-9097-7
- By:
- Publication type:
- Article
Newer mechanical devices in the management of acute heart failure.
- Published in:
- Heart Failure Reviews, 2007, v. 12, n. 2, p. 167
- By:
- Publication type:
- Article
248 Use of a Propensity Score to Examine Association between Rates of In-Hospital Decongestion and Mortality and Cardiovascular Outcomes Among Patients admitted for Acute Heart Failure.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction.
- Published in:
- JAMA: Journal of the American Medical Association, 2013, v. 310, n. 23, p. 2533, doi. 10.1001/jama.2013.282190
- By:
- Publication type:
- Article
Rejoinder.
- Published in:
- Clinical Trials, 2017, v. 14, n. 2, p. 126, doi. 10.1177/1740774516688917
- By:
- Publication type:
- Article
Data monitoring committees: Promoting best practices to address emerging challenges.
- Published in:
- Clinical Trials, 2017, v. 14, n. 2, p. 115, doi. 10.1177/1740774516688915
- By:
- Publication type:
- Article
Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Management of heart failure.
- Published in:
- JAMA: Journal of the American Medical Association, 1994, v. 272, n. 17, p. 1361, doi. 10.1001/jama.1994.03520170071039
- By:
- Publication type:
- Article
Effects of angiotensin converting enzyme inhibitor enalapril on the long-term progression of left...
- Published in:
- JAMA: Journal of the American Medical Association, 1993, v. 269, n. 14, p. 1862
- By:
- Publication type:
- Article
THE FUTURE OF CARDIOVASCULAR CARE: FROM AFFORDABLE CARE TO THE ACADEMIC MEDICAL CENTER.
- Published in:
- Transactions of the American Clinical & Climatological Association, 2018, v. 129, p. 301
- By:
- Publication type:
- Article
Dosing of losartan in men versus women with heart failure with reduced ejection fraction: the HEAAL trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
For vaptans, as for life, balance is better.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 5, p. 751, doi. 10.1002/ejhf.2042
- By:
- Publication type:
- Article
Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ventricular remodelling: an equal‐opportunity prognosticator.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 12, p. 2269, doi. 10.1002/ejhf.1991
- By:
- Publication type:
- Article
Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial.
- Published in:
- 2020
- By:
- Publication type:
- clinical trial
Rationale and design of the EMPERIAL-Preserved and EMPERIAL-Reduced trials of empagliflozin in patients with chronic heart failure.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Relation between therapy-induced changes in natriuretic peptide levels and long-term therapeutic effects on mortality in patients with heart failure and reduced ejection fraction.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Seeking therapeutic precision in heart failure: is ejection fraction really the way? Deconstructing the CHARM of heart failure with mid-range ejection fraction.
- Published in:
- 2018
- By:
- Publication type:
- editorial
Hyperkalaemia in heart failure: binding the patient to improved treatment?
- Published in:
- 2015
- By:
- Publication type:
- commentary
Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.
- Published in:
- European Journal of Heart Failure, 2013, v. 15, n. 12, p. 1401
- By:
- Publication type:
- Article
Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial.
- Published in:
- European Journal of Heart Failure, 2013, v. 15, n. 11, p. 1228, doi. 10.1093/eurjhf/hft100
- By:
- Publication type:
- Article
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document.
- Published in:
- European Journal of Heart Failure, 2013, v. 15, n. 10, p. 1082, doi. 10.1093/eurjhf/hft095
- By:
- Publication type:
- Article
Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction†.
- Published in:
- European Journal of Heart Failure, 2013, v. 15, n. 6, p. 679, doi. 10.1093/eurjhf/hft023
- By:
- Publication type:
- Article
Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial.
- Published in:
- European Journal of Heart Failure, 2013, v. 15, n. 2, p. 194, doi. 10.1093/eurjhf/hfs153
- By:
- Publication type:
- Article
Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial.
- Published in:
- European Journal of Heart Failure, 2013, v. 15, n. 1, p. 61, doi. 10.1093/eurjhf/hfs139
- By:
- Publication type:
- Article
Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trial.
- Published in:
- European Journal of Heart Failure, 2012, v. 14, n. 12, p. 1401, doi. 10.1093/eurjhf/hfs145
- By:
- Publication type:
- Article
Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial.
- Published in:
- European Journal of Heart Failure, 2012, v. 14, n. 3, p. 302
- By:
- Publication type:
- Article
Hypoalbuminaemia and incident heart failure in older adults.
- Published in:
- European Journal of Heart Failure, 2011, v. 13, n. 10, p. 1078, doi. 10.1093/eurjhf/hfr088
- By:
- Publication type:
- Article
Hyponatraemia and vasopressin in heart failure: markers or mediators?
- Published in:
- European Journal of Heart Failure, 2011, v. 13, n. 3, p. 242, doi. 10.1093/eurjhf/hfq236
- By:
- Publication type:
- Article
Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial.
- Published in:
- European Journal of Heart Failure, 2010, v. 12, n. 4, p. 367, doi. 10.1093/eurjhf/hfq019
- By:
- Publication type:
- Article
LETTERS.
- Published in:
- 2001
- By:
- Publication type:
- Letter
Utility of In Vivo, Intracardiac Two-Dimensional Echocardiography in the Assessment of Myocardial Risk Area and Myocardial Dyssynergy During Coronary Occlusion and Reperfusion.
- Published in:
- Echocardiography, 1994, v. 11, n. 1, p. 71, doi. 10.1111/j.1540-8175.1994.tb01049.x
- By:
- Publication type:
- Article
Real-Time, Intracardiac, Two-Dimensional Echocardiography.
- Published in:
- Echocardiography, 1991, v. 8, n. 4, p. 407, doi. 10.1111/j.1540-8175.1991.tb01002.x
- By:
- Publication type:
- Article
Experimental Observations on Intracavitary Imaging of Cardiac Structures with 20-MHz Ultrasound Catheters.
- Published in:
- Echocardiography, 1991, v. 8, n. 1, p. 127, doi. 10.1111/j.1540-8175.1991.tb01410.x
- By:
- Publication type:
- Article
Intravascular and Intracardiac Ultrasound Imaging: Current Research and Future Directions.
- Published in:
- Echocardiography, 1990, v. 7, n. 4, p. 377, doi. 10.1111/j.1540-8175.1990.tb00378.x
- By:
- Publication type:
- Article
Advances in Our Clinical Understanding of Autonomic Regulation Therapy Using Vagal Nerve Stimulation in Patients Living With Heart Failure.
- Published in:
- Frontiers in Physiology, 2022, v. 13, p. 1, doi. 10.3389/fphys.2022.857538
- By:
- Publication type:
- Article